AbbVie saw fourth-quarter sales handily beat Wall Street's projections as gains from its newer anti-inflammatory drugs helped offset declines from Humira, once its best performing asset. The drugmaker ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...